Proactiv Md Adapalene Acne Treatmentadapalene

According to the FDA label: Use For the treatment of acne

179,844 adverse event reports submitted to the FDA (2004–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Proactiv Md Adapalene Acne Treatment in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Proactiv Md Adapalene Acne Treatment adverse event reports by reporter sex
SexReports
Female123,126
Male34,905
Unknown68

By Age Group

View age group data as a table
Proactiv Md Adapalene Acne Treatment adverse event reports by reporter age group
Age groupReports
0-1736,759
18-3435,599
35-4910,019
50-643,094
65-74962
75+399

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Proactiv Md Adapalene Acne Treatment. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Proactiv Md Adapalene Acne Treatment adverse event reports by reported outcome
OutcomeReports
Non-Serious179,249
Other Serious464
Hospitalization150
Life-Threatening27
Death18
Disability10

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Proactiv Md Adapalene Acne Treatment. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Proactiv Md Adapalene Acne Treatment adverse event reports by year
YearReports
20041
20062
20072
20082
20093
20105
20118
201218
201312
201416
201537
201640
2017152
201825,238
201955,445
202058,413
202123,479
20223,729
20235,214
20244,093
20251,209
2026 (partial)2,726

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Proactiv Md Adapalene Acne Treatment

In FDA adverse event reports that mention Proactiv Md Adapalene Acne Treatment, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026